Article
Expansion of Bone Precursors through Jun as a Novel Treatment for Osteoporosis-Associated Fractures.
Stem cell reports - 14 Apr 2020
Lerbs Tristan, Cui Lu, Muscat Claire, Saleem Atif, van Neste Camille, Domizi Pablo, Chan Charles, Wernig Gerlinde
Abstract excerpt
Osteoporosis and osteoporotic fractures lead to decreased life quality and high healthcare costs. Current treatments prevent losses in bone mass and fractures to some extent but have side effects. Therefore, better therapies are needed. This study investigated whether the transcription factor Jun has a specific pro-osteogenic potency and whether modulating Jun could serve as a novel treatment for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
